Therapy for non-muscle invasive bladder cancer: HP-NAP

Marco Racioppi, Pierfrancesco Bassi, Alessio Filianoti, Daniele D’Agostino, Luca Di Gianfrancesco, Gaia Codolo, Matteo Fassan, Fabio Munari, Massimo Rugge, Mario Milco D’Elios, Marina De Bernard, Francesco Pagano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

Purpose: Patients with non-muscle invasive bladder cancer recurrence after 2 induction courses of BCG are eligible for radical cystectomy. So, in the last years research to discover new drugs for the management of non-muscle invasive bladder cancer recurrence after failure of first and second line therapy is ongoing. In accordance to the results obtained with BCG, whose mechanism depends on the induction of the T helper 1 (TH1) immune response, we investigated the activity of a Toll-like receptor (TLR) 2 ligand, named Helicobacter Pylori Neutrophil Activating Protein (HP-NAP), that we recently demonstrated being able of enhancing the differentiation of Th1 cells, both in vitro and in vivo, because of its ability to create an IL-12 enriched milieu. Materials and Methods: We show here, in a mouse model of bladder neoplasm implants, that local administration of HP-NAP decreases tumor growth by inducing tumor necrosis. Results: The result is joined up with a massive cluster of both CD4+ and CD8+ IFN-γ+ cells, within neoplasm and regional lymph nodes. It is of note that HP-NAP-treated tumors show also a reduced vascularization due to the anti-angiogenic activity of IFN-γ induced by HP-NAP. Conclusions: The present study suggeststhat the activity of HP-NAP against urothelial tumor burden warrants subsequent in vivo studies.
Titolo tradotto del contributo[Autom. eng. transl.] Therapy for non-muscle invasive bladder cancer: HP-NAP
Lingua originaleItalian
pagine (da-a)142-148
Numero di pagine7
RivistaUrologia
Volume79
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • HP-NAP
  • Tumore della Vescica

Fingerprint

Entra nei temi di ricerca di 'Therapy for non-muscle invasive bladder cancer: HP-NAP'. Insieme formano una fingerprint unica.

Cita questo